<DOC>
	<DOCNO>NCT01973023</DOCNO>
	<brief_summary>Chronic stroke patient exhibit gait pattern alteration mainly due spasticity treat repetitive multifocal botulinum toxin injection ( BTI ) . Several study demonstrate single BTI-session single muscle paretic low limb ( LL ) improve kinematic gait parameter ( GP ) surprisingly none assessed effect repetitive multifocal BTI patient 's gait pattern duration . The aim evaluate impact repetitive multifocal BTI-sessions GP chronic stroke patient . To end , gait patient compare use 3D-gait analysis least 2 consecutive BTI session .</brief_summary>
	<brief_title>Stroke 's Gait Pattern Modifications Induced Repeated BTI</brief_title>
	<detailed_description>All patient tretaed BTI . injection perform electrical stimulation control ( ~5mA ) . The dose , number site injection per muscle discretion physician accord patient ' need physician ' routine clinical practice . The dilution commonly use depend type BoNT-A ( BOTOX® , XEOMIN® DYSPORT® ) 100 U 2.5ml ( BOTOX® XEOMIN® ) 500 U 2.5 ml ( Dysport® ) .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>&gt; 18 year single hemispheric cerebral vascular lesion 6 month previously able walk 10 meter without assistance benefit least 2 consecutive BTI session , second 3D gait analysis perform least 3 month last BTI . patient 's refusal participate study Inability read select text Inability cooperate No affiliation social security</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>botulinum toxin injection</keyword>
	<keyword>stroke</keyword>
	<keyword>3D motion analysis</keyword>
	<keyword>gait pattern</keyword>
</DOC>